The MAC Clause Trap: How Material Adverse Change Clauses Can Kill Your M&A Deal

Why MAC Clauses Are the Single Most Litigated Provision in M&A Agreements

Most founders treat material adverse change (MAC) clauses as boilerplate — a few paragraphs buried in Section 5 of the acquisition agreement that their deal lawyer handles on autopilot. That assumption can be fatal. MAC clauses (also called material adverse effect or MAE clauses) are the single most litigated provision in M&A acquisition agreements. They determine whether a buyer can walk away from a signed deal without paying a breakup fee, and the case law interpreting them has become a multi-billion-dollar battleground in Delaware Chancery Court.

Here is the problem: between signing and closing, things change. Markets shift, key customers churn, regulatory issues surface. The MAC clause is the contractual mechanism that allocates risk for those changes. If a MAC has occurred, the buyer can refuse to close — and in some cases terminate the agreement entirely. If no MAC has occurred, the buyer must close or face breach-of-contract liability, including reverse termination fees that can run into the tens of millions.

We have seen founders lose deals — and watch buyers renegotiate purchase prices downward by 20% or more — because they accepted a broadly drafted MAC clause that gave the buyer an escape hatch they never anticipated. Understanding how Delaware courts actually interpret these provisions, and what you can negotiate before signing, is essential to protecting your exit.

What Constitutes a Material Adverse Change Under Delaware Law

Delaware courts have established a demanding, fact-intensive standard for what constitutes a material adverse change. The foundational test requires that the alleged change substantially threaten the overall earnings potential of the target company in a durationally significant manner. As the Delaware Court of Chancery has repeatedly emphasized, this means the impact must be measured in years, not months — a short-term hiccup, however painful, does not qualify (Fenwick & West, "Akorn v. Fresenius: Important Practical Lessons").

Three dimensions define the analysis:

Duration

The adverse change must persist long enough to be "durationally significant." Delaware courts have signaled that quarters of decline are relevant but not dispositive — the question is whether the change threatens the company's earnings potential over a multi-year horizon. A single bad quarter, even a very bad one, is unlikely to satisfy this standard on its own.

Magnitude

The change must be quantitatively or qualitatively significant enough to "substantially threaten" the target's overall earnings potential. Courts have resisted establishing bright-line percentage thresholds, but the Akorn decision provides the only data point where a court actually found an MAE: remediation costs projected to reduce the company's value by approximately 21% were deemed sufficient (Fenwick & West analysis of Akorn v. Fresenius).

Qualitative vs. Quantitative

Delaware courts evaluate materiality from "the longer-term perspective of a reasonable acquiror." Both qualitative factors (such as regulatory compliance failures that strike at the core of the business) and quantitative factors (such as percentage declines in revenue or enterprise value) are weighed together. The court has made clear that no single metric is dispositive — the inquiry is inherently fact-specific.

Akorn v. Fresenius: The First (and Still Only) Time Delaware Enforced a MAC Clause

For decades, M&A lawyers could confidently tell clients that no Delaware court had ever found a material adverse effect. That changed on October 1, 2018, when Vice Chancellor Travis Laster issued his post-trial opinion in Akorn, Inc. v. Fresenius Kabi AG, 2018 WL 4719347 (Del. Ch. Oct. 1, 2018), aff'd, 198 A.3d 724 (Del. 2018). The Delaware Supreme Court affirmed the decision in December 2018 (Harvard Law School Forum on Corporate Governance, "Material Adverse Effect Clauses and the Delaware Supreme Court").

The facts were extraordinary. After signing a merger agreement in April 2017, Akorn's financial performance collapsed. Over four consecutive quarters, revenues declined 29%, 29%, 34%, and 27% respectively compared to the prior year. Operating income fell even more dramatically — 84%, 89%, 292%, and 134% declines. This was not a short-term blip; it was a sustained, systemic deterioration.

But the financial decline was only half the story. Fresenius also discovered that Akorn had serious FDA compliance failures — including data integrity problems so fundamental that one former consultant testified he would not expect to see them "at a company that made Styrofoam cups." Akorn had submitted fabricated data to the FDA and failed to investigate whistleblower allegations. The court found that remediation costs would reduce Akorn's value by approximately $900 million — a 21% decline — which was sufficient to establish a quantitative MAE (Fenwick & West analysis).

The court also found that Akorn had breached its obligation to operate in the "ordinary course of business" between signing and closing. The lesson: a target company cannot simply maintain the status quo during the signing-to-closing gap — it must react reasonably to new circumstances, regardless of the pending merger.

Why Akorn Remains Unique

Despite the fears that Akorn would open the floodgates, it remains the only Delaware decision finding a standalone MAE. The facts were egregious: a 29%+ sustained revenue decline, fabricated FDA data, and a wholesale failure of regulatory compliance at a pharmaceutical company. Courts have repeatedly distinguished Akorn on its facts, emphasizing that the MAE standard remains "a high bar" that buyers will continue to struggle to meet (Harvard Law School Forum on Corporate Governance, "Court of Chancery Decision Provides Guidance for Drafting MAE Clauses").

Post-COVID MAE Litigation: The Snow Phipps Decision

When the COVID-19 pandemic hit in early 2020, buyers across the M&A landscape scrambled to invoke MAC clauses to escape signed deals. The most significant test case was Snow Phipps Group, LLC v. KCAKE Acquisition, Inc., 2021 WL 1714202 (Del. Ch. Apr. 30, 2021), where the buyer argued that COVID-19's impact on the target's business constituted an MAE.

The court rejected the claim. The decision reinforced several critical principles:

• Industry-wide carve-outs apply: The MAC clause's standard carve-out for industry-wide effects meant that the pandemic's general economic disruption did not qualify as an MAE, even though it hurt the target.
• Disproportionate impact must be proven: To overcome an industry-wide carve-out, the buyer must show that the change affected the target disproportionately compared to others in its industry. General economic conditions — even pandemic-level disruptions — are exactly what the carve-outs are designed to exclude.
• Ordinary course covenants are not violated by reasonable pandemic responses: The target's efforts to navigate COVID-19 (furloughs, cost-cutting, operational adjustments) did not breach its ordinary course covenant because they were reasonable responses to the circumstances.

The Snow Phipps decision confirmed that MAC clauses remain buyer-hostile under Delaware law. As one analysis noted, the decision "provided further clarity" that pandemic-era disruptions fall squarely within standard MAE carve-outs (Harvard Law School Forum on Corporate Governance, "Court of Chancery Finds Pandemic Was Not an MAE"). For a deeper dive on the broader closing conditions that can kill your deal during the signing-to-closing gap, see our prior guide.

Industry-Specific vs. Systemic Carve-Outs: What They Mean for Your Deal

MAC clauses typically include a list of carve-outs — conditions that, even if adverse, do not count as a material adverse change. The standard carve-outs include general economic conditions, changes in financial or banking markets, changes in law or regulation, and acts of war or terrorism. The critical negotiation point is whether these carve-outs include a disproportionate effect qualifier.

Without a disproportionate effect qualifier, a carve-out completely removes the condition from MAC analysis. If the clause says "changes in general economic conditions shall not constitute an MAE," then a recession cannot trigger the MAC — period. With a disproportionate effect qualifier, the carve-out only applies unless the condition disproportionately affects the target compared to others in its industry. This gives the buyer a potential argument that even a general economic downturn qualifies as an MAE if the target was hit harder than its peers.

For sellers, the goal is to maximize carve-outs and minimize the disproportionate effect qualifier. For buyers, the opposite is true. This single drafting choice can determine whether a buyer can walk.

How to Negotiate MAC Definitions That Protect Sellers

If you are a founder preparing to sell your company, the MAC clause is not something to accept on the first draft. Here are the specific negotiating moves that can protect your deal:

1. Narrow the Definition of "Adverse Change"

Push for a MAC definition that requires a material adverse effect on the company's business, properties, financial condition, or results of operations, taken as a whole. The "taken as a whole" language is standard but important — it prevents the buyer from cherry-picking a single business line or segment that suffered while others remained healthy.

2. Add Disproportionate Effect Qualifiers to Carve-Outs

As a seller, you want broad carve-outs (macroeconomic conditions, industry-wide effects, changes in law) with no disproportionate effect qualifier. This ensures that even if your company is disproportionately affected by a recession, the buyer cannot argue the carve-out does not apply.

3. Require a Quantitative Threshold

Some sellers successfully negotiate language requiring that the adverse change result in a decline of a specified percentage (e.g., 15-20%) in revenue or EBITDA over a specified period. While Delaware courts resist bright-line tests, this language gives you a contractual argument that short-term or modest declines are per se immaterial.

4. Limit the Look-Back Period

Negotiate language requiring that the adverse change be "durationally significant" and explicitly state that changes lasting less than a specified period (e.g., six months or one year) do not qualify. This forces the buyer to prove sustained, long-term impact.

5. Carve Out Known Issues

If there are known risks — a pending lawsuit, a regulatory inquiry, a key customer concentration issue — negotiate to explicitly exclude them from the MAC definition. The buyer cannot claim surprise about something it knew about at signing.

Practical Strategies When a Buyer Threatens to Invoke a MAC

If a buyer threatens to invoke a MAC clause after signing, do not panic — but do not capitulate. Here is what to do:

1. Demand specificity. Require the buyer to identify the specific changes it claims constitute a MAC. Vague assertions about "market conditions" or "the business has deteriorated" are insufficient. Force them to articulate the quantitative and qualitative basis for the claim.
2. Assess carve-out coverage. Immediately analyze whether the claimed adverse change falls within a contractual carve-out. If it does, the buyer's argument fails at the threshold — regardless of severity.
3. Document compliance with ordinary course covenants. Ensure you are operating the business reasonably and in the ordinary course. The Akorn court made clear that a target must react to new circumstances appropriately — not freeze in place. Document your reasonable business decisions.
4. Assess the disproportionality argument. If the buyer relies on a carve-out with a disproportionate effect qualifier, gather industry data showing that your company's performance is not worse than peers. If everyone in your sector experienced the same headwinds, the disproportionate effect argument fails.
5. Engage counsel immediately. MAC disputes escalate quickly and can end up in Delaware Chancery Court within days. The moment a buyer raises a MAC concern, you need experienced M&A litigation counsel involved — not just your deal lawyer. Consider our deal-readiness playbook for pre-signing preparation that reduces this risk.
6. Consider a price renegotiation as a fallback. If the buyer has a colorable MAC argument — even if not a winning one — the practical reality is that litigation is expensive and uncertain. A negotiated price reduction may be preferable to months of Chancery Court litigation, especially if the signing-to-closing gap is long.

Actionable Next Steps

Before you sign an acquisition agreement, take these steps to protect yourself from a MAC clause trap:

• Review the MAC definition line by line with your M&A counsel. Do not accept the buyer's first draft. Every word matters.
• Negotiate broad carve-outs for macroeconomic conditions, industry-wide effects, and changes in law — without disproportionate effect qualifiers where possible.
• Require quantitative thresholds and duration requirements that give you a contractual argument against short-term or modest declines.
• Draft a robust ordinary course covenant that acknowledges the need to respond reasonably to changing circumstances — and then operate accordingly between signing and closing.
• Pre-position for MAC disputes by documenting industry comparables, maintaining regular business operations, and keeping detailed records of your response to any adverse developments.
• Build a relationship with M&A litigation counsel before you need them. When a buyer threatens a MAC, you need to move fast.

The MAC clause is not boilerplate. It is the single most important risk-allocation provision in your acquisition agreement — and the one most likely to determine whether your deal closes at the price you negotiated, or falls apart when the market shifts. Treat it accordingly.